What does the Oncotype DX report tell you?
Oncotype DX® is a tumor profiling test. It helps determine the benefit of using chemotherapy in addition to hormone therapy to treat some estrogen receptor-positive (ER-positive) breast cancers.
What treatment would you recommend if the Oncotype DX test score is 10?
A prospective study shows that women with an Oncotype DX test Recurrence Score between 0 and 10 can safely be treated only with hormonal therapy, allowing them to skip chemotherapy.
How reliable is oncotype?
21-gene RS accurately predicted 97% of the low RS stratified patients to avoid receiving chemotherapy. However, addition of chemotherapy in the treatment regimen for node positive, Her-2/neu positive, high Ki-67, and PR negative tumors may be beneficial regardless of 21-gene RS.
How to pronounce Oncotype DX?
Pronunciation of oncotype with 1 audio pronunciations 0 rating rating ratings Record the pronunciation of this word in your own voice and play it to listen to how you have pronounced it.
How to read Oncotype results?
A low recurrence score is 25 and under.
Who does Oncotype DX testing?
The Oncotype DX GPS assay is performed on claims with the unique proprietary laboratory analysis (PLA) code, 0047U. Exact Sciences believes that everyone should have access to the information they need to make confident, informed decisions about their cancer treatments.
When is Oncotype testing done?
The Oncotype DX Breast Recurrence Score test is a diagnostic test performed on the tumor tissue removed from your breast during your surgery or biopsy. You may be a candidate for the Breast Recurrence Score test if: You have been recently diagnosed with invasive breast cancer. Your cancer is anatomic stage I, II, or IIIa.